What is the most commonly prescribed drug for osteoporosis?

What is the most commonly prescribed drug for osteoporosis?

Bisphosphonates are usually the first choice for osteoporosis treatment. These include: Alendronate (Fosamax), a weekly pill. Risedronate (Actonel), a weekly or monthly pill.

What is the best oral medication for osteoporosis?

ANSWER: Oral bisphosphonate drugs — including alendronate (Fosamax), risedronate (Actonel and Atelvia) and ibandronate (Boniva) — are the most commonly prescribed osteoporosis drugs. Bisphosphonates are less expensive than the alternatives, are safe in the long term, and are effective in preventing fractures.

What is the best medication for osteoporosis prevention?

Risedronate – Risedronate (brand names: Actonel, Atelvia) reduces the risk of both vertebral and hip fractures. Risedronate is approved for both prevention and treatment of osteoporosis. It can be taken once per day, once per week, or once per month.

What is the best and safest natural treatment for osteoporosis?

While more scientific research is needed on the subject, some herbs and supplements are believed to reduce or potentially stop the bone loss caused by osteoporosis.

• Red clover. Red clover is thought to contain estrogen-like compounds.
• Soy.
• Black cohosh.
• Horsetail.
• Acupuncture.
• Tai chi.
• Melatonin.
• Traditional treatment options.

What is conbriza used for?

Conbriza is used for the treatment of osteoporosis (a disease that makes bones fragile) in women who have been through the menopause. It is used in women who are at risk of fracture (broken bones). Conbriza has been shown to significantly reduce fractures in the spine but not in the hip. The medicine can only be obtained with a prescription.

How effective is conbriza for fracture prevention?

After three years, 2% of the patients receiving Conbriza (35 out of 1,724) had new fractures compared with 4% of those receiving placebo (59 out of 1,741). The difference was more relevant in the sub-group of women at higher risk of fractures before the study.

How does conbriza affect bone density?

After two years, the average bone density remained almost unchanged in women who received Conbriza, but in women who received placebo it was reduced by over 1%. In both main studies the effects of Conbriza were similar to the effects of raloxifene.

What is conbriza (bazedoxifene)?

The active substance in Conbriza, bazedoxifene, is a selective oestrogen receptor modulator (SERM). Bazedoxifene acts as an ‘agonist’ of the oestrogen receptor (a substance that stimulates the receptor for oestrogen) in some tissues in the body. Bazedoxifene has the same effect as oestrogen in the bone.